Secondhand Tobacco Smoke and COPD Risk in Smokers: A COPDGene Study Cohort Subgroup Analysis - PubMed (original) (raw)
Secondhand Tobacco Smoke and COPD Risk in Smokers: A COPDGene Study Cohort Subgroup Analysis
Ian van Koeverden et al. COPD. 2015 Apr.
Abstract
Background: Exposure to secondhand tobacco smoke (SHS) can be a risk factor for chronic obstructive pulmonary disease (COPD), but its role among relatively heavy smokers with potential co-exposure to workplace vapors, gas, dust, and fumes (VGDF) has not been studied.
Methods: To estimate the contribution of SHS exposure to COPD risk, taking into account smoking effects and work-related exposures to VGDF, we quantified SHS based on survey responses for 1400 ever-employed subjects enrolled in the COPDGene study, all current or former smokers with or without COPD. Occupational exposures to VGDF were quantified based on a job exposure matrix. The associations between SHS and COPD were tested in multivariate logistic regression analyses adjusted for age, sex, VGDF exposure, and cumulative smoking.
Results and discussion: Exposures to SHS at work and at home during adulthood were associated with increased COPD risk: odds ratio (OR) = 1.12 (95% confidence interval [CI]: 1.02-1.23; p = 0.01) and OR = 1.09 (95%CI: 1.00-1.18; p = 0.04) per 10 years of exposure adjusted for smoking and other covariates, respectively. In addition, subjects with employment histories likely to entail exposure to VGDF were more likely to have COPD: OR = 1.52 (95%CI: 1.16-1.98; p < 0.01) (adjusted for other covariates). While adult home SHS COPD risk was attenuated among the heaviest smokers within the cohort, workplace SHS and job VGDF risks persisted in that stratum.
Conclusion: Among smokers all with at least 10 pack-years, adult home and work SHS exposures and occupational VGDF exposure are all associated with COPD.
Keywords: COPD; cigarette smoking; job exposure matrix; occupational exposure; secondhand tobacco smoke; work-related.
Conflict of interest statement
Declaration of Interest Statement
The authors do not have any conflict of interest to disclose.
Figures
Figure 1
COPD risk factors in a subgroup of the COPDGene study cohort in adjusted modeling. Forest plot of odds ratios for presence of COPD (FEV1 to FVC ratio less than LLN and FEV1 <80% predicted) of adult home and workplace SHS exposure after adjustment for vapors, gas, dust, and fumes (VGDF) occupational exposure and other covariates.
Similar articles
- Occupational exposures and the risk of COPD: dusty trades revisited.
Blanc PD, Iribarren C, Trupin L, Earnest G, Katz PP, Balmes J, Sidney S, Eisner MD. Blanc PD, et al. Thorax. 2009 Jan;64(1):6-12. doi: 10.1136/thx.2008.099390. Epub 2008 Aug 4. Thorax. 2009. PMID: 18678700 Free PMC article. - Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies.
Sack CS, Doney BC, Podolanczuk AJ, Hooper LG, Seixas NS, Hoffman EA, Kawut SM, Vedal S, Raghu G, Barr RG, Lederer DJ, Kaufman JD. Sack CS, et al. Am J Respir Crit Care Med. 2017 Oct 15;196(8):1031-1039. doi: 10.1164/rccm.201612-2431OC. Am J Respir Crit Care Med. 2017. PMID: 28753039 Free PMC article. - Chronic Obstructive Pulmonary Disease (COPD) and Vapors, Gases, Dusts, or Fumes (VGDF): A Meta-analysis.
Ryu JY, Sunwoo YE, Lee SY, Lee CK, Kim JH, Lee JT, Kim DH. Ryu JY, et al. COPD. 2015 Aug;12(4):374-80. doi: 10.3109/15412555.2014.949000. COPD. 2015. PMID: 25255043 - Occupational COPD and job exposure matrices: a systematic review and meta-analysis.
Sadhra S, Kurmi OP, Sadhra SS, Lam KB, Ayres JG. Sadhra S, et al. Int J Chron Obstruct Pulmon Dis. 2017 Feb 22;12:725-734. doi: 10.2147/COPD.S125980. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28260879 Free PMC article. Review. - Secondhand smoke at work.
Eisner MD. Eisner MD. Curr Opin Allergy Clin Immunol. 2010 Apr;10(2):121-6. doi: 10.1097/ACI.0b013e32833649b3. Curr Opin Allergy Clin Immunol. 2010. PMID: 20035220 Review.
Cited by
- Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers.
Mustra Rakic J, Zeng S, Rohdin-Bibby L, Van Blarigan EL, Liu X, Ma S, Kane JP, Redberg RF, Turino GM, Oestreicher Stock E, Arjomandi M. Mustra Rakic J, et al. Chronic Obstr Pulm Dis. 2022 Jul 29;9(3):377-393. doi: 10.15326/jcopdf.2022.0289. Chronic Obstr Pulm Dis. 2022. PMID: 35700534 Free PMC article. - Klotho as Potential Autophagy Regulator and Therapeutic Target.
Zhou H, Pu S, Zhou H, Guo Y. Zhou H, et al. Front Pharmacol. 2021 Oct 19;12:755366. doi: 10.3389/fphar.2021.755366. eCollection 2021. Front Pharmacol. 2021. PMID: 34737707 Free PMC article. Review. - Lung volumes identify an at-risk group in persons with prolonged secondhand tobacco smoke exposure but without overt airflow obstruction.
Arjomandi M, Zeng S, Geerts J, Stiner RK, Bos B, van Koeverden I, Keene J, Elicker B, Blanc PD, Gold WM. Arjomandi M, et al. BMJ Open Respir Res. 2018 May 5;5(1):e000284. doi: 10.1136/bmjresp-2018-000284. eCollection 2018. BMJ Open Respir Res. 2018. PMID: 29755755 Free PMC article. - What are the Differences Between Smoker and Non-smoker COPD Cases? Is it a Different Phenotype?
Güldaval F, Polat G, Doruk S, Karadeniz G, Ayranci A, Türk M, Gayaf M, Yavuz MY, Büyükşirin M, Anar C. Güldaval F, et al. Turk Thorac J. 2021 Jul;22(4):284-288. doi: 10.5152/TurkThoracJ.2021.20147. Turk Thorac J. 2021. PMID: 35110244 Free PMC article.
References
- Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Ruttenvan Molken MP. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Amer J Respir Crit Care Med. 2001;164(4):590–596. - PubMed
- Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773. - PubMed
- Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD) Lancet. 2004;364(9434):613–620. - PubMed
- GOLD. Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Revised 2011) 2011 [12/29/2012]; Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf. - PubMed
- Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 182(5):693–718. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL089897/HL/NHLBI NIH HHS/United States
- U01 HL08-9856/HL/NHLBI NIH HHS/United States
- UL1 RR025780/RR/NCRR NIH HHS/United States
- U01 HL089897/HL/NHLBI NIH HHS/United States
- K23 HL08-3099/HL/NHLBI NIH HHS/United States
- R01 HL089856/HL/NHLBI NIH HHS/United States
- U01 HL089856/HL/NHLBI NIH HHS/United States
- U01 HL08-9897/HL/NHLBI NIH HHS/United States
- K23 HL083099/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical